FDA approval for kids' vaccines may take longer | Pfizer submitted it initial data

Pfizer tested a lower dose of the shots in children. The drug maker said last week that researchers found the vaccine developed corona virus-fighting antibody levels in children that were just as strong as those found in teenagers and young adults getting regular-strength doses.
The FDA already has scientists reviewing that initial data submitted by Pfizer,
Pfizer Covid-19 vaccine for kids may not be available until November.
Just 64.8% of Americans ages 12 and up are fully vaccinated against COVID-19

More than 692,000 Americans have died from COVID-19 while over 4.7 million people have died from the disease worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.

This prediction comes after Dr. Anthony Fauci said Tuesday kids will likely start getting vaccinated by late October.
Pfizer submitted it initial data on younger children to the FDA earlier Tuesday.
Pfizer,Coronavirus Vaccine,children,us,kids, vaccinated,fda,FDA approval,Pfizer submitted it initial data,shots in children,Americans,vaccinated against COVID-19,COVID-19 updates,united states, younger children,Covid-19 vaccine for kids,october,not available,latest news,today news,breaking news,us news,news updates,headlines,29 sept. 2021, 29 september